Clinical Study of Jianfei Kangfu Cao in the Treatment of pSS-ILD
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Interstitial Lung Disease
- Primary Sjögren's Syndrome
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
This study will be a randomized, double-blind, positive control clinical trial with a course of 24 weeks. Random scheme:the DAS for Interactive Web Response System(IWRS) will be used to calculate and distribute random numbers and dispensing drugs. Blind method ?The test process will be in a double-b...
This study will be a randomized, double-blind, positive control clinical trial with a course of 24 weeks. Random scheme:the DAS for Interactive Web Response System(IWRS) will be used to calculate and distribute random numbers and dispensing drugs. Blind method ?The test process will be in a double-blind state. Control drug: The lung rehabilitation training will be used as control in this trial.
Tracking Information
- NCT #
- NCT04544722
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Zhujing Zhu, Ph.D Longhua Hospital Study Chair: Jianchun Mao, Master Longhua Hospital Study Chair: Huanru Qu, Ph.D Longhua Hospital
Get Well Soon